Gary Kelloff
Overview
Explore the profile of Gary Kelloff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torka P, Pederson L, Knopp M, Poon D, Zhang J, Kahl B, et al.
Cancer Med
. 2023 Feb;
12(7):8211-8217.
PMID: 36799072
Background: Quantitative methods of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) interpretation, including the percent change in FDG uptake from baseline (ΔSUV), are under investigation in lymphoma to overcome challenges associated with...
2.
Connors D, Allen J, Alvarez J, Boyle J, Cristofanilli M, Hiller C, et al.
Crit Rev Oncol Hematol
. 2020 Oct;
156:103112.
PMID: 33035734
The promise of precision medicine as a model to customize health care to the individual patient is heavily dependent upon new genetic tools to classify and characterize diseases and their...
3.
Maitland M, Wilkerson J, Karovic S, Zhao B, Flynn J, Zhou M, et al.
Clin Cancer Res
. 2020 Sep;
26(24):6464-6474.
PMID: 32988968
Purpose: Mathematical models combined with new imaging technologies could improve clinical oncology studies. To improve detection of therapeutic effect in patients with cancer, we assessed volumetric measurement of target lesions...
4.
Schoder H, Polley M, Knopp M, Hall N, Kostakoglu L, Zhang J, et al.
Blood
. 2020 Apr;
135(25):2224-2234.
PMID: 32232481
As part of a randomized, prospective clinical trial in large cell lymphoma, we conducted serial fluorodeoxyglucose positron emission tomography (FDG-PET) at baseline, after 2 cycles of chemotherapy (interim PET [i-PET]),...
5.
Dercle L, Connors D, Tang Y, Adam S, Gonen M, Hilden P, et al.
JCO Clin Cancer Inform
. 2019 Jan;
2:1-12.
PMID: 30652552
Purpose: To develop a public-private partnership to study the feasibility of a new approach in collecting and analyzing clinically annotated imaging data from landmark phase III trials in advanced solid...
6.
Leptak C, Menetski J, Wagner J, Aubrecht J, Brady L, Brumfield M, et al.
Sci Transl Med
. 2017 Nov;
9(417).
PMID: 29167393
Biomarkers can facilitate all aspects of the drug development process. However, biomarker qualification-the use of a biomarker that is accepted by the U.S. Food and Drug Administration-needs a clear, predictable...
7.
Keeney M, Wood B, Hedley B, DiGiuseppe J, Stetler-Stevenson M, Paietta E, et al.
Cytometry B Clin Cytom
. 2017 May;
94(2):239-249.
PMID: 28475275
Background: Minimal residual disease (MRD) in B lymphoblastic leukemia (B-ALL) by flow cytometry is an established prognostic factor used to adjust treatment in most pediatric therapeutic protocols. MRD in B-ALL...
8.
Clarke L, Nordstrom R, Zhang H, Tandon P, Zhang Y, Redmond G, et al.
Transl Oncol
. 2014 Apr;
7(1):1-4.
PMID: 24772201
The purpose of this editorial is to provide a brief history of National Institutes of Health National Cancer Institute (NCI) workshops as related to quantitative imaging within the oncology setting....
9.
Lanza G, Moonen C, Baker Jr J, Chang E, Cheng Z, Grodzinski P, et al.
Wiley Interdiscip Rev Nanomed Nanobiotechnol
. 2013 Dec;
6(1):1-14.
PMID: 24339356
Imaging has become a cornerstone for medical diagnosis and the guidance of patient management. A new field called image-guided drug delivery (IGDD) now combines the vast potential of the radiological...
10.
DeMichele A, Berry D, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski J, et al.
Clin Cancer Res
. 2013 Mar;
19(11):2817-23.
PMID: 23470967
New approaches to drug development are critically needed to lessen the time, cost, and resources necessary to identify and optimize active agents. Strategies to accelerate drug development include testing drugs...